How do you differentiate between dacryocystitis and dacryostenosis in an adult patient with no significant past medical history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differentiating Dacryocystitis from Dacryostenosis

Dacryocystitis is an infection/inflammation of the lacrimal sac presenting with pain, swelling, erythema, and purulent discharge at the medial canthal region, while dacryostenosis is a chronic narrowing or obstruction of the nasolacrimal duct presenting primarily with epiphora (tearing) without acute inflammatory signs.

Clinical Presentation

Dacryocystitis

  • Acute inflammatory signs: Pain, tenderness, erythema, and swelling over the lacrimal sac area (medial canthus below the medial canthal tendon) 1, 2
  • Purulent discharge: Expressible from the punctum with pressure over the lacrimal sac 2
  • Systemic symptoms: May include fever and malaise in acute cases 2
  • Complications: Can progress to preseptal or orbital cellulitis, abscess formation, and rarely vision loss 3
  • Microbiology: Predominantly gram-positive bacteria, especially Staphylococcus aureus, though gram-negative bacteria, anaerobes, and fungi can occur 4

Dacryostenosis (Nasolacrimal Duct Obstruction)

  • Primary symptom: Chronic epiphora without acute inflammatory signs 5, 6
  • Recurrent infections: History of repeated mild infections or chronic low-grade dacryocystitis 2
  • No acute inflammation: Absence of pain, erythema, warmth, or purulent discharge in uncomplicated cases 6
  • Functional obstruction: Patent canaliculi but obstructed nasolacrimal duct confirmed by irrigation 5

Key Differentiating Features

Physical Examination Findings

  • Dacryocystitis: Tender, erythematous, fluctuant mass at medial canthus; purulent material expressible from punctum; possible preseptal cellulitis 1, 2
  • Dacryostenosis: Non-tender lacrimal sac; clear tear lake; positive regurgitation test (reflux of clear or mucoid material with lacrimal sac compression) 5

Diagnostic Testing

  • Lacrimal irrigation: In dacryostenosis, irrigation demonstrates obstruction with reflux through the opposite punctum; in acute dacryocystitis, irrigation should be deferred until infection resolves 5, 1
  • Cultures: Indicated in dacryocystitis to guide antibiotic therapy, especially given increasing MRSA prevalence 4
  • Imaging: CT or MRI may be needed in dacryocystitis complicated by orbital involvement to assess for abscess formation 3

Clinical Pitfalls

Critical warning: Acute dacryocystitis can rapidly progress to orbital cellulitis and abscess formation with risk of permanent vision loss 3. Monitor carefully for:

  • Proptosis
  • Restricted extraocular motility
  • Decreased vision
  • Orbital pain with eye movement

These signs mandate urgent imaging and possible surgical drainage 3.

Common mistake: Attempting nasolacrimal duct probing during acute dacryocystitis. The infection must be controlled with intravenous antibiotics first, followed by definitive surgical treatment 1-2 days later 2.

Management Implications

Dacryocystitis

  • Acute cases: Hospital admission for intravenous antibiotics, monitoring for orbital complications, followed by surgical intervention (probing in children, dacryocystorhinostomy in adults with chronic disease) 1, 2
  • Chronic/recurrent: Dacryocystorhinostomy is the definitive treatment 5, 6

Dacryostenosis

  • Conservative management initially: Warm compresses, massage, topical antibiotics for secondary conjunctivitis 2
  • Definitive treatment: Dacryocystorhinostomy when conservative measures fail and functional lacrimal pump is intact 5, 6

Age consideration: In pediatric patients, chronic low-grade dacryocystitis from dacryostenosis can be managed with outpatient probing, while acute dacryocystitis requires inpatient management 2. Success rates for dacryocystorhinostomy in children (83%) are comparable to adults when proper surgical technique is employed 6.

References

Research

Spectrum of pediatric dacryocystitis: medical and surgical management of 54 cases.

Journal of pediatric ophthalmology and strabismus, 1997

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dacryocystorhinostomy: History, evolution and future directions.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society, 2011

Research

Pediatric dacryocystorhinostomy.

Archives of ophthalmology (Chicago, Ill. : 1960), 1985

Related Questions

What other medications should be given to a patient with vision loss due to orbital cellulitis?
Can a healthcare provider prescribe Terracortil (hydrocortisone) and Tobrex (tobramycin) for Dacryocystitis?
What is the treatment for dacrocystitis?
What is the management approach for dacrocystitis?
What treatment options are available for a 14-year-old experiencing a burning sensation in one eye with constant watering, but no discharge, while currently using allergy medications and eye drops, with a suspected inflamed tear duct?
What is the equivalence between capacidad funcional (functional capacity) classifications 1, 2, and 3 and Metabolic Equivalents (METS) in patients with cardiovascular disease?
What are the considerations for using Insulin and Jardiance (empagliflozin) together in a patient with type 2 diabetes, particularly those with comorbidities such as heart failure or impaired renal function?
What is the recommended treatment for a patient with a widespread ringworm infection that started on the abdomen and has spread to the shoulders, groin, and neck, requiring both systemic and topical therapies?
What are the diagnostic criteria and treatment approaches for dysthymic disorder (Persistent Depressive Disorder) versus Major Depressive Disorder (MDD) in a patient presenting with depressive symptoms?
How to prescribe Micronor (norethindrone) to a 40-year-old patient with diabetes (impaired glucose regulation) and hypercholesterolemia (elevated lipid profiles) for contraception?
Can ramelteon (ramelteon) be broken in half if it's causing excessive daytime sleepiness in a patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.